Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency

References

• LopezADMathersCDEzzatiMJamisonDTMurrayCJGlobal and regional burden of disease and risk factors, 2001: systematic analysis of population health dataLancet200636795241747175716731270
   PubMed Web of Science ®Google Scholar
• PorapakkhamYRaoCPattaraarchachaiJEstimated causes of death in Thailand, 2005: implications for health policyPopul Health Metr201081420482761
   PubMed Web of Science ®Google Scholar
• GrundySMCleemanJIMerzCNImplications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesCirculation2004110222723915249516
   PubMed Web of Science ®Google Scholar
• SchwartzGGOlssonAGEzekowitzMDEffects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trialJAMA2001285131711171811277825
   PubMed Web of Science ®Google Scholar
• LibbyPTherouxPPathophysiology of coronary artery diseaseCirculation2005111253481348815983262
   PubMed Web of Science ®Google Scholar
• CannonCPBraunwaldEMcCabeCHIntensive versus moderate lipid lowering with statins after acute coronary syndromesN Engl J Med2004350151495150415007110
   PubMed Web of Science ®Google Scholar
• de LemosJABlazingMAWiviottSDEarly intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trialJAMA2004292111307131615337732
   PubMed Web of Science ®Google Scholar
• RayKKCannonCPMcCabeCHEarly and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 TrialJ Am Coll Cardiol20054681405141016226162
   PubMed Web of Science ®Google Scholar
• ReinerZCatapanoALDe BackerGESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)Eur Heart J201132141769181821712404
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsExecutive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)JAMA2001285192486249711368702
   PubMed Web of Science ®Google Scholar
• WengTCYangYHLinSJTaiSHA systematic review and meta-analysis on the therapeutic equivalence of statinsJ Clin Pharm Ther201035213915120456733
   PubMed Web of Science ®Google Scholar
• TarnYHHuSKamaeIHealth-care systems and pharmacoeconomic research in Asia-Pacific regionValue Health200811Suppl 1S137S15518387058
   PubMed Web of Science ®Google Scholar
• AnothaisintaweeTLeelahavarongPRatanapakornTTeerawattananonYThe use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand’s pharmaceutical benefit packageClinicoecon Outcomes Res2012436137423248574
   PubMedGoogle Scholar
• ChinCWGaoFLeTTanRLipid goal attainment and prescription behavior in asian patients with acute coronary syndromes: experience from a tertiary hospitalClin Med Insights Cardiol20137515723533099
   PubMedGoogle Scholar
• KauffmanABOlsonKLYoungbloodMLZadvornyEBDelateTMerenichJAAttainment of low-density lipoprotein cholesterol goals in coronary artery diseaseJ Clin Lipidol20104317318021122649
   PubMed Web of Science ®Google Scholar
• KitkungvanDLynn FilliponNMDaniSSDowneyBCLow-density lipoprotein cholesterol target achievement in patients at high risk for coronary heart diseaseJ Clin Lipidol20104429329721122662
   PubMed Web of Science ®Google Scholar
• SukonthasarnAHomsanitMPrommeteBChotinaiwattarakulCPiamsomboonCLikittanasombatKLipid-lowering treatment in hypercholesterolemic patients: the CEPHEUS Thailand surveyJ Med Assoc Thai201194121424143422295727
   PubMedGoogle Scholar
• KaralisDGVictorBAhedorLLiuLUse of lipid-lowering medications and the likelihood of achieving optimal LDL-cholesterol goals in coronary artery disease patientsCholesterol2012201286192422888414
   PubMedGoogle Scholar
• KaralisDGSubramanyaRDHessenSELiuLVictorMFAchieving optimal lipid goals in patients with coronary artery diseaseAm J Cardiol2011107688689021247526
   PubMed Web of Science ®Google Scholar
• ParkJEChiangCEMunawarMLipid-lowering treatment in hypercholesterolaemic patients: the CEPHEUS Pan-Asian surveyEur J Prev Cardiol201219478179421450606
   PubMed Web of Science ®Google Scholar
• SilaruksSSriratanasathavornCRawdareePKunjara-Na-AyudhayaRThinkhamropBSritaraPLipid-lowering therapy using statins in patients with cardiovascular risk in clinical practice in ThailandHeart Asia2011399103
   PubMedGoogle Scholar
• XanthopoulouIDavlourosPSiahosSPerperisAZaharioglouEAlexopoulosDFirst-line treatment patterns and lipid target levels attainment in very high cardiovascular risk outpatientsLipids Health Dis2013121701217023391102
   PubMedGoogle Scholar
• AndrikopoulosGTzeisSNikasNShort-term outcome and attainment of secondary prevention goals in patients with acute coronary syndrome-Results from the countrywide TARGET studyInt J Cardiol2013168292292723186596
   PubMed Web of Science ®Google Scholar
• KimHSWuYLinSJCurrent status of cholesterol goal attainment after statin therapy among patients with hypercholesterolemia in Asian countries and region: the Return on Expenditure Achieved for Lipid Therapy in Asia (REALITY-Asia) studyCurr Med Res Opin20082471951196318547466
   PubMed Web of Science ®Google Scholar
• MelloniCShahBROuFSLipid-lowering intensification and low-density lipoprotein cholesterol achievement from hospital admission to 1-year follow-up after an acute coronary syndrome event: results from the Medications ApplIed aNd SusTAINed Over Time (MAINTAIN) registryAm Heart J201016061121112921146667
   PubMed Web of Science ®Google Scholar
• ChanRHChanPHChanKKThe CEPHEUS Pan-Asian survey: high low-density lipoprotein cholesterol goal attainment rate among hypercholesterolaemic patients undergoing lipid-lowering treatment in a Hong Kong regional centreHong Kong Med J201218539540623018067
   PubMed Web of Science ®Google Scholar
• MukhtarRYReidJRecklessJPPitavastatinInt J Clin Pract200559223925215854203
   PubMed Web of Science ®Google Scholar
• MasanaLPitavastatin – from clinical trials to clinical practiceAtheroscler Suppl2010113152221193154
   PubMed Web of Science ®Google Scholar
• RosenbaumPRRubinDBThe central role of the propensity score in observational studies for causal effectsBiometrika19837014155
   Web of Science ®Google Scholar
• AustinPCAn introduction to propensity score methods for reducing the effects of confounding in observational studiesMultivariate Behav Res201146339942421818162
   PubMed Web of Science ®Google Scholar
• D’AgostinoRBPropensity scores in cardiovascular researchCirculation2007115172340234317470708
   PubMed Web of Science ®Google Scholar
• RallidisLSKotakosCSouridesVAttainment of optional low-density lipoprotein cholesterol goal of less than 70 mg/dL and impact on prognosis of very high risk stable coronary patients: a 3-year follow-upExpert Opin Pharmacother201112101481148921651448
   PubMed Web of Science ®Google Scholar
• HermansMPCastro CabezasMStrandbergTCentralized Pan-European survey on the under-treatment of hypercholesterolaemia (CEPHEUS): overall findings from eight countriesCurr Med Res Opin201026244545420001658
   PubMed Web of Science ®Google Scholar
• ChaiyakunaprukNAsupholODhippayomTPoowaruttanawiwitPJeanpeerapongNStatins utilisation pattern: a retrospective evaluation in a tertiary care hospital in ThailandInt J Pharm Pract201119212913521385244
   PubMedGoogle Scholar
• Van GanseELaforestLAlemaoEDaviesGGutkinSYinDLipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) studyCurr Med Res Opin20052191389139916197657
   PubMed Web of Science ®Google Scholar
• SteinEStenderSMataPAchieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatinAm Heart J2004148344745515389231
   PubMed Web of Science ®Google Scholar
• DavidsonMHMcGarryTBettisREzetimibe coadministered with simvastatin in patients with primary hypercholesterolemiaJ Am Coll Cardiol200240122125213412505224
   PubMed Web of Science ®Google Scholar
• FriedmanHSRajagopalanSBarnesJPRosemanHCombination therapy with ezetimibe/simvastatin versus statin monotherapy for low-density lipoprotein cholesterol reduction and goal attainment in a real-world clinical settingClin Ther201133221222421497705
   PubMed Web of Science ®Google Scholar
• FoodyJMTothPPTomassiniJEChanges in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapyVasc Health Risk Manag2013971972724265554
   PubMedGoogle Scholar
• DavidsonMHReducing residual risk for patients on statin therapy: the potential role of combination therapyAm J Cardiol2005969A3K13K
   PubMed Web of Science ®Google Scholar
• MikhailidisDPLawsonRWMcCormickALComparative efficacy of the addition of ezetimibe to statin vs statin titration in patients with hypercholesterolaemia: systematic review and meta-analysisCurr Med Res Opin20112761191121021473671
   PubMed Web of Science ®Google Scholar
• TothPPFoodyJMTomassiniJETherapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular diseaseJ Clin Lipidol20148110711624528691
   PubMed Web of Science ®Google Scholar
• VaughanCJGottoAMJrUpdate on statins: 2003Circulation2004110788689215313959
   PubMed Web of Science ®Google Scholar
• IllingworthDRManagement of hypercholesterolemiaMed Clin North Am2000841234210685126
   PubMed Web of Science ®Google Scholar
• National Drug CommitteeNational List of Essential Medicines 2008Bangkok, ThailandSri-muang Kanpim2008
   Google Scholar
• OseLBudinskiDHounslowNArnesonVComparison of pitavastatin with simvastatin in primary hypercholesterolaemia or combined dyslipidaemiaCurr Med Res Opin200925112755276419785568
   PubMed Web of Science ®Google Scholar
• GizurarsonSBjornsdottirLREinarsdottirRHalldorssonMAndersenKClinical consequences following regulatory changes in respect to reimbursement of statins cost by the Icelandic Social Insurance AdministrationScand J Public Health201240766366723027893
   PubMed Web of Science ®Google Scholar
• ParrisESLawrenceDBMohnLALongLBAdherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemiaDiabetes Care200528359559915735194
   PubMed Web of Science ®Google Scholar
• HoPMBrysonCLRumsfeldJSMedication adherence: its importance in cardiovascular outcomesCirculation2009119233028303519528344
   PubMed Web of Science ®Google Scholar
• BerminghamMHaydenJDawkinsIProspective analysis of LDL-C goal achievement and self-reported medication adherence among statin users in primary careClin Ther20113391180118921840055
   PubMed Web of Science ®Google Scholar
• JackeviciusCAMamdaniMTuJVAdherence with statin therapy in elderly patients with and without acute coronary syndromesJAMA2002288446246712132976
   PubMed Web of Science ®Google Scholar
• LaforestLMoulinPSouchetTCorrelates of LDL-cholesterol goal attainment in patients under lipid lowering therapyAtherosclerosis2008199236837718191135
   PubMed Web of Science ®Google Scholar
• GittAKDrexelHFeelyJPersistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and CanadaEur J Prev Cardiol201219222123021450578
   PubMed Web of Science ®Google Scholar
• HoKTChinKWNgKSAlemaoERajagopalanSYinDThe A-SACT (Achievement in Singapore of Cholesterol Targets) study in patients with coronary heart diseaseAm J Cardiovasc Drugs20066638339117192128
   PubMedGoogle Scholar
• StoneNJRobinsonJGLichtensteinAH2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesJ Am Coll Cardiol20146325 Pt B2889293424239923
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care ExcellenceLipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular DiseaseLondon, UKNational Clinical Guideline Centre2014 Available from: http://www.nice.org.uk/guidance/cg181/resources/guidance-lipid-modification-cardiovascular-risk-assessment-and-the-modification-of-blood-lipids-for-the-primary-and-secondary-prevention-of-cardiovascular-disease-pdfAccessed November 27, 2014
   Google Scholar
• JacobsonTAItoMKMakiKCNational Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summaryJ Clin Lipidol20148547348825234560
   PubMed Web of Science ®Google Scholar